PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsDacarbazine
Dacarbazine
Dacarbazine (dacarbazine) is a small molecule pharmaceutical. Dacarbazine was first approved as Dtic-dome on 1982-01-01. It is used to treat fibrosarcoma, hodgkin disease, islet cell carcinoma, medullary carcinoma, and melanoma amongst others in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
neoplasmsD009369
digestive system diseasesD004066
hemic and lymphatic diseasesD006425
skin and connective tissue diseasesD017437
endocrine system diseasesD004700
immune system diseasesD007154
Trade Name
FDA
EMA
Dacarbazine (discontinued: Dacarbazine, Dtic-dome)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Dacarbazine
Tradename
Company
Number
Date
Products
DTIC-DOMEBayerN-017575 DISCN1982-01-01
2 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
aleve arthritis pain gelANDA2023-11-30
amazon basic care arthritis painANDA2024-05-17
arthritis painANDA2024-12-01
arthritis pain relieverANDA2025-06-25
arthritis pain relievingANDA2023-05-15
arthrotecNew Drug Application2024-12-02
aspercreme arthritisANDA2025-01-28
basic care arthritis painANDA2022-01-06
berkley and jensen arthritis painANDA2023-07-26
biorepair sensitive teethunapproved drug other2017-06-13
Show 124 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
L: Antineoplastic and immunomodulating agents
L01: Antineoplastic agents
L01A: Alkylating agents
L01AX: Other alkylating agents in atc
L01AX04: Dacarbazine
HCPCS
Code
Description
J9130
Dacarbazine, 100 mg
Clinical
Clinical Trials
281 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MelanomaD00854520593812105
Hodgkin diseaseD006689C81655263892
LymphomaD008223C85.9653263890
Disseminated intravascular coagulationD004211D652411017
Neoplasm metastasisD009362EFO_00097084216
Non-hodgkin lymphomaD008228C85.9112
Ankylosing spondylitisD013167EFO_0003898M4511
SpondylarthritisD02524111
SpondylitisD013166M46.911
Axial spondyloarthritisD00008918311
Show 1 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SarcomaD0125093118120
LeiomyosarcomaD0078901459
SepsisD018805EFO_0001420A41.911158
Uveal neoplasmsD014604EFO_1001230627
NeoplasmsD009369C803316
NeuroblastomaD009447EFO_00006211416
ToxemiaD0141151146
Skin neoplasmsD012878EFO_0004198C44335
Cutaneous malignant melanomaD000096142134
LiposarcomaD00808033
Show 12 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
CarcinomaD002277C80.0223
Neuroendocrine tumorsD018358EFO_1001901D3A.8213
ImmunotherapyD007167122
OsteosarcomaD012516122
Hiv infectionsD015658EFO_0000764B20122
Urologic neoplasmsD014571C64-C6811
Urinary bladder neoplasmsD001749C6711
Transitional cell carcinomaD00229511
Thyroid neoplasmsD013964EFO_0003841111
Thyroid diseasesD013959E00-E07111
Show 13 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Blood coagulation disordersD001778EFO_0009314D68.9134
Hemostatic disordersD020141134
Lung neoplasmsD008175C34.90213
Healthy volunteers/patients22
Small cell carcinomaD01828811
Small cell lung carcinomaD05575211
Carcinoid tumorD002276D3A.0011
Parathyroid neoplasmsD01028211
Renal cell carcinomaD002292EFO_000037611
Breast neoplasmsD001943EFO_0003869C5011
Show 3 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Septic shockD012772A48.333
Pressure ulcerD003668L8922
ShockD012769R57.122
Non-small-cell lung carcinomaD00228911
HivD006678O98.711
ContraceptionD00326711
UlcerD014456MPATH_57911
Snake bitesD012909T63.011
Iridocorneal endothelial syndromeD05712911
Placenta previaD010923EFO_0007442O4411
Show 22 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDacarbazine
INNdacarbazine
Description
Dacarbazine is a monocarboxylic acid amide that is 1H-imidazole-4-carboxamide which is substituted at position 5 by a 3,3-dimethyltriaz-1-en-1-yl group. It is used for the treatment of metastatic malignant melanoma, and in combination with other drugs for the treatment of Hodgkin's disease and soft-tissue sarcoma. It has a role as an antineoplastic agent, an alkylating agent, a prodrug and a carcinogenic agent. It is a monocarboxylic acid amide, a member of imidazoles and a triazene derivative.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CN(C)/N=N/c1[nH]cnc1C(N)=O
Identifiers
PDB
CAS-ID1185241-28-4
RxCUI
ChEMBL IDCHEMBL476
ChEBI ID
PubChem CID2942
DrugBankDB00851
UNII ID7GR28W0FJI (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
£
Keveyis Strongbridge Biopharma
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Keveyis Xeris Biopharma Holdings
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Zipsor Assertio Therapeutics
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Zipsor Assertio Therapeutics
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Lidocaine Amneal Pharmaceuticals
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Lidocaine Amphastar Pharmaceuticals
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Arthrotec Pfizer
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Cambia Assertio Therapeutics
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Cambia Assertio Therapeutics
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Diclofenac Amneal Pharmaceuticals
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Diclofenac Novartis
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 2,171 documents
View more details
Safety
Black-box Warning
Black-box warning for: Arthrotec, Cambia, Capsinac, Clofenax, Dacarbazine, Dicloenac sodium and misoprostol, Diclofenac, Diclofenac epolamine, Diclofenac potassium, Diclofenac potassium for oral solution, Diclofenac sodium 1.5%, Diclofenac sodium and misoprostol, Diclofenac sodium d/r, Diclofenac sodium delayed release, Diclofenac sodium diclofenac sodium, Diclofenac sodium extended-release, Diclofenac sodium gel, Diclofenac sodium misoprostol, Diclofenac sodium topical sol, Diclofenac sodium topical solution, Diclofenac sodium/misoprostol, Diclogen, Diclosaicin, Diclostream, Diclotral pak, Diclovix m, Diclozor, Dimentho, Fenovar, Flector, Flexipak, Iclofenac cp, Inflatherm, Lefluniclo, Lextol, Licart, Lixofen, Lofena, Orthaphen, Pennsaid, Profinac, Varophen, Venngel ii, Venngel one, Ziclopro, Zipsor, Zorvolex
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
135,899 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use